Skip to content

IPHA

Innate Pharma SA

NASDAQ · Healthcare · Biotechnology · FR

$1.90
−0.52%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
3.61x
P/S forward
93.99x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
-4.57x
Price / sales
170.58x
Price / cash flow
-4.13x

Enterprise value

Enterprise value
$212.2M
EV / sales
170.52x
EV / EBITDA
-3.52x
EV / EBIT
-3.71x
Market cap
$212.2M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026